单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China华中科技大学同济医学院附属同济医院[2]Kunming Med Univ, Affiliated Hosp 2, Kunming, Yunnan, Peoples R China[3]Third Mil Med Univ, Xingiao Hosp, Inst Canc, Chongqing, Peoples R China
第一作者单位：[1]Huazhong Univ Sci & Technol, Tongji Hosp, Tongji Med Coll, Wuhan, Hubei, Peoples R China
推荐引用方式(GB/T 7714)：
Chu Qian,Huang Shanshan,Gao Yuan,et al.Anti-VEGF therapy sensitizes EGFR/MET co-altered NSCLC cells to TKIs via inhibiting the VEGF/ERK/MET pathway[J].CANCER RESEARCH.2020,80(16):doi:10.1158/1538-7445.AM2020-1874.
APA：
Chu, Qian,Huang, Shanshan,Gao, Yuan,Lin, Jie,Chen, Yuan...&Wu, Kongming.(2020).Anti-VEGF therapy sensitizes EGFR/MET co-altered NSCLC cells to TKIs via inhibiting the VEGF/ERK/MET pathway.CANCER RESEARCH,80,(16)
MLA：
Chu, Qian,et al."Anti-VEGF therapy sensitizes EGFR/MET co-altered NSCLC cells to TKIs via inhibiting the VEGF/ERK/MET pathway".CANCER RESEARCH 80..16(2020)
医学